Abbott LaboratoriesABTNYSE
Loading
EPS Diluted Over TimeContracting
Percentile Rank71
3Y CAGR-1.6%
5Y CAGR+8.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
-1.6%/yr
vs +30.7%/yr prior
5Y CAGR
+8.3%/yr
Recent deceleration
Acceleration
-32.3pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.72 | -51.3% |
| 2024 | 7.64 | +133.6% |
| 2023 | 3.27 | -16.4% |
| 2022 | 3.91 | -0.8% |
| 2021 | 3.94 | +57.6% |
| 2020 | 2.50 | +21.4% |
| 2019 | 2.06 | +53.7% |
| 2018 | 1.34 | +396.3% |
| 2017 | 0.27 | -71.3% |
| 2016 | 0.94 | - |